TAS-102 in Treating Advanced Biliary Tract Cancers
Conditions
- Cholangiocarcinoma
- Stage III Gallbladder Cancer AJCC v7
- Stage IIIA Gallbladder Cancer AJCC v7
- Stage IIIB Gallbladder Cancer AJCC v7
- Stage IV Gallbladder Cancer AJCC v7
- Stage IVA Gallbladder Cancer AJCC v7
- Stage IVB Gallbladder Cancer AJCC v7
Interventions
- OTHER: Laboratory Biomarker Analysis
- DRUG: Trifluridine/Tipiracil Hydrochloride Combination Agent TAS-102
Sponsor
Mayo Clinic
Collaborators